15585627

Source:http://linkedlifedata.com/resource/pubmed/id/15585627

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0017837, umls-concept:C0024305, umls-concept:C0030705, umls-concept:C0032105, umls-concept:C0205179, umls-concept:C0441771, umls-concept:C1514474
pubmed:issue	23
pubmed:dateCreated	2004-12-8
pubmed:abstractText	This study aims to investigate whether the plasma level of glutathione S-transferase P1-1 (GSTP1-1), which is a phase II detoxifying enzyme known to be a resistance factor for anticancer drugs, could be a prognostic factor of de novo non-Hodgkin lymphoma (NHL) in clinical stages (CSs) III and IV.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9502500
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/GSTP1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Glutathione S-Transferase pi, http://linkedlifedata.com/resource/pubmed/chemical/Glutathione Transferase, http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes, http://linkedlifedata.com/resource/pubmed/chemical/Prednisone, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1078-0432
pubmed:author	pubmed-author:HayashiTsuyoshiT, pubmed-author:IkedaTatsuruT, pubmed-author:KatahiraTatsuroT, pubmed-author:KatoJunjiJ, pubmed-author:MatsunagaTakuyaT, pubmed-author:MiyanishiKojiK, pubmed-author:NiitsuYoshiroY, pubmed-author:TakahashiYasuoY, pubmed-author:TakayamaTetsujiT, pubmed-author:TakimotoRishuR
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	10
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	7934-40
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:15585627-Adult, pubmed-meshheading:15585627-Aged, pubmed-meshheading:15585627-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15585627-Cyclophosphamide, pubmed-meshheading:15585627-Disease Progression, pubmed-meshheading:15585627-Doxorubicin, pubmed-meshheading:15585627-Female, pubmed-meshheading:15585627-Glutathione S-Transferase pi, pubmed-meshheading:15585627-Glutathione Transferase, pubmed-meshheading:15585627-Humans, pubmed-meshheading:15585627-Isoenzymes, pubmed-meshheading:15585627-Lymphoma, B-Cell, pubmed-meshheading:15585627-Lymphoma, Large B-Cell, Diffuse, pubmed-meshheading:15585627-Lymphoma, Non-Hodgkin, pubmed-meshheading:15585627-Male, pubmed-meshheading:15585627-Middle Aged, pubmed-meshheading:15585627-Prednisone, pubmed-meshheading:15585627-Prognosis, pubmed-meshheading:15585627-Survival Rate, pubmed-meshheading:15585627-Time Factors, pubmed-meshheading:15585627-Treatment Outcome, pubmed-meshheading:15585627-Vincristine
pubmed:year	2004
pubmed:articleTitle	Plasma glutathione S-Transferase P1-1 as a prognostic factor in patients with advanced non-Hodgkin's lymphoma (stages III and IV).
pubmed:affiliation	Fourth Department of Internal Medicine, Sapporo Medical University, School of Medicine, South-1, West-16, Chuo-ku, Sapporo, 060-8543, Japan.
pubmed:publicationType	Journal Article